“…In addition, researchers have pointed out the need to utilise a collaborative team approach to successfully treat people with a history of substance abuse for HCV that relies on the input of a number of health care providers, including primary care physicians, HCV specialists, psychiatrists/psychologists, social workers, and drug counsellors (Edlin, 2002;Sylvestre et al, 2004). Yet, many HCV-positive drug users are likely to have difficulty obtaining comprehensive evaluation and care from a multidisciplinary team of medical providers, as this population often has limited access to health care services (Bae, 1997;Chitwood, McBride, French, & Comerford, 1999;Contoreggi, Rexroad, & Lange, 1998) and people with HCV are more likely to be uninsured or have publicly-funded health care (NIH, 2002). Given the large number of medically uninsured drug users in this country and the high cost of HCV medications ($15,000 or more for a full course of treatment in the U.S.), many infected individuals have to apply for financial assistance programmes funded by pharmaceutical companies to pay for treatment (Schering-Plough, 2006).…”